theralizumab
0 sources
theralizumab
Summary
theralizumab is a monoclonal antibody[1]. theralizumab ranks in the top 10% of monoclonal_antibody entities by monthly Wikipedia readership (143 views/month).[2]
Key Facts
- theralizumab's instance of is recorded as monoclonal antibody[3].
- theralizumab's instance of is recorded as experimental drug[4].
- theralizumab's CAS Registry Number is recorded as 906068-56-2[5].
- theralizumab's Freebase ID is recorded as /m/0c09yn[6].
- theralizumab's UNII is recorded as POO0DOD3AS[7].
- theralizumab's DrugBank ID is recorded as DB15717[8].
- theralizumab's Microsoft Academic ID is recorded as 2778210076[9].
Why It Matters
theralizumab ranks in the top 10% of monoclonal_antibody entities by monthly Wikipedia readership (143 views/month).[2] theralizumab has Wikipedia articles in 11 language editions, a strong signal of global cultural recognition.[10] theralizumab is known by 5 alternative names across languages and contexts.[11]